DORM

Dorman Products, Inc.

59
Fundamentals46/ 100
Valuation59/ 100
Upside potential58/ 100
Risk potential18/ 100

DORM has the edge over NIO overall, supported by stronger valuation and lower modeled downside.

NIO

NIO Inc.

56
Fundamentals77/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential27/ 100

NIO offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

DORM Fundamentals

MetricStatus
Stable
Stable
Strong
Healthy

DORM's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.

NIO Fundamentals

MetricStatus
Strong
Stable
Stable
Unavailable

NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.

DORM PE Valuation

CHEAPFAIREXPENSIVE11x21x32x42x
CHEAPFAIREXPENSIVE11x21x32x42x
LevelPEPriceVs current
Forward15x$132—
Cheap19x$125-5.6%
Current20x$132—
Fair23x$152+15%
Expensive28x$191+45%

Historical ranges are pointers, not guarantees.

DORM's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.

NIO PE Valuation

NIO has no meaningful PE right now: it lost money over the past year.

DORM Forward outlook

MetricOutlook
Strongly improving
Growth
Stable
Improving
Limited
Moderate

Analysts expect DORM's earnings to grow and its profitability to improve, with its revenue holding steady.

NIO Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Strongly improving
Limited
Moderate

NIO has the edge over DORM on the outlook, with more favorable revenue expectations.

DORM Risk to reward

ScenarioChangePrice
Upside+25%$164.52
Downside-18%$108.33

Calculated from the latest close: $132.00 on Nov 12.

DORM trails NIO on modeled risk to reward, with less potential upside relative to its potential downside.

NIO Risk to reward

ScenarioChangePrice
Upside+38%$4.21
Downside-27%$2.22

Calculated from the latest close: $3.05 on Nov 12.

NIO has a better modeled risk to reward balance than DORM, with more potential upside relative to its potential downside.

DORM Earnings Per Share

Q4 2023: $4.10Q1 2024: $4.97Q2 2024: $5.46Q3 2024: $5.98Q4 2024: $6.14Q1 2025: $6.96Q2 2025: $7.34Q3 2025: $8.02Q4 2025: $6.64Q1 2026: $6.20Q2 2026: $7.22Q3 2026: $6.72Forward: $8.63
Q4 2023: $4.10Q1 2024: $4.97Q2 2024: $5.46Q3 2024: $5.98Q4 2024: $6.14Q1 2025: $6.96Q2 2025: $7.34Q3 2025: $8.02Q4 2025: $6.64Q1 2026: $6.20Q2 2026: $7.22Q3 2026: $6.72Forward: $8.63
QuarterTTM EPSYoY
Forward$8.63+28%
Q3 2026$6.72-16%
Q2 2026$7.22-1.6%
Q1 2026$6.20-11%
Q4 2025$6.64+8.1%
Q3 2025$8.02+34%
Q2 2025$7.34+34%
Q1 2025$6.96+40%
Q4 2024$6.14+50%

DORM has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.

NIO Earnings Per Share

Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
QuarterTTM EPSYoY
Q2 2026-$0.29+$1.45
Q1 2026-$0.60+$1.16
Q4 2025-$1.06+$0.60
Q3 2025-$1.59+$0.02
Q2 2025-$1.74-$0.10
Q1 2025-$1.76+$0.06
Q4 2024-$1.66+$0.21
Q3 2024-$1.61+$0.32

NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.

DORM Quarterly Revenue

Q4 2023: $494MQ1 2024: $469MQ2 2024: $503MQ3 2024: $504MQ4 2024: $534MQ1 2025: $508MQ2 2025: $541MQ3 2025: $544MQ4 2025: $538MQ1 2026: $529MQ2 2026: $545MQ3 2026: $562M
Q4 2023: $494MQ1 2024: $469MQ2 2024: $503MQ3 2024: $504MQ4 2024: $534MQ1 2025: $508MQ2 2025: $541MQ3 2025: $544MQ4 2025: $538MQ1 2026: $529MQ2 2026: $545MQ3 2026: $562M
QuarterRevenueYoY
Q3 2026$561.7M+3.3%
Q2 2026$544.6M+0.7%
Q1 2026$528.8M+4.2%
Q4 2025$537.9M+0.8%
Q3 2025$543.7M+7.9%
Q2 2025$541M+7.6%
Q1 2025$507.7M+8.3%
Q4 2024$533.8M+8%

DORM's revenue has grown year over year for 11 quarters in a row: $562M last quarter, up 3.3% from the same quarter a year ago.

NIO Quarterly Revenue

Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
QuarterRevenueYoY
Q2 2026$4.8B+69%
Q1 2026$3.8B+112%
Q4 2025$5.2B+76%
Q3 2025$3.3B+17%
Q2 2025$2.9B+9%
Q1 2025$1.8B+21%
Q4 2024$3B+15%
Q3 2024$2.8B-2.1%

NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.

DORM Free Cash Flow

Q4 2023: $49MQ1 2024: $41MQ2 2024: $51MQ3 2024: $36MQ4 2024: $63MQ1 2025: $40MQ2 2025: $98,000Q3 2025: $2MQ4 2025: $33MQ1 2026: $35MQ2 2026: $144MQ3 2026: $57M
Q4 2023: $49MQ1 2024: $41MQ2 2024: $51MQ3 2024: $36MQ4 2024: $63MQ1 2025: $40MQ2 2025: $98,000Q3 2025: $2MQ4 2025: $33MQ1 2026: $35MQ2 2026: $144MQ3 2026: $57M
QuarterFree cash flowYoY
Q3 2026$56.9M+3022%
Q2 2026$143.5M+146376%
Q1 2026$35.3M-12%
Q4 2025$33.5M-47%
Q3 2025$1.8M-95%
Q2 2025$98K-100%
Q1 2025$40.3M-2.4%
Q4 2024$63.2M+30%

DORM generated $269M in free cash flow over the past year, up 155% from the year before.

NIO Free Cash Flow

Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
QuarterFree cash flowYoY
Q2 2026$0+$2.1B
Q1 2026$0$0
Q4 2025$0+$391.3M
Q3 2025$0$0
Q2 2025-$2.1B+$73.9M
Q1 2025$0$0
Q4 2024-$391.3M-386%
Q2 2024-$2.2B+$337.9M

NIO has the edge over DORM on cash flow, with more consistent year-over-year improvement.

DORM Total Shares

Q4 2023: 32MQ1 2024: 31MQ2 2024: 31MQ3 2024: 31MQ4 2024: 31MQ1 2025: 31MQ2 2025: 31MQ3 2025: 31MQ4 2025: 31MQ1 2026: 30MQ2 2026: 30MQ3 2026: 30M
Q4 2023: 32MQ1 2024: 31MQ2 2024: 31MQ3 2024: 31MQ4 2024: 31MQ1 2025: 31MQ2 2025: 31MQ3 2025: 31MQ4 2025: 31MQ1 2026: 30MQ2 2026: 30MQ3 2026: 30M
PeriodChange %Net change
Quarterly-0.5%-135K shares
1 year-3%-922K shares
3 years-5.4%-1.7M shares
5 years-6.2%-2M shares
Available history-8.7%-2.8M shares

DORM has the edge over NIO on shareholder dilution, with a more favorable share count trend.

NIO Total Shares

Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
PeriodChange %Net change
Quarterly+0.6%+15.6M shares
1 year+12%+267M shares
3 years+51%+844M shares
5 years+60%+933M shares
Available history+143%+1.5B shares

NIO has 2.5B diluted shares, up 12% from a year ago.

DORM Net Leverage

Q4 2023: 1.7xQ1 2024: 1.5xQ2 2024: 1.3xQ3 2024: 1.3xQ4 2024: 1.2xQ1 2025: 1.1xQ2 2025: 1.1xQ3 2025: 1.0xQ4 2025: 1.1xQ1 2026: 1.2xQ2 2026: 0.8xQ3 2026: 0.8x
Q4 2023: 1.7xQ1 2024: 1.5xQ2 2024: 1.3xQ3 2024: 1.3xQ4 2024: 1.2xQ1 2025: 1.1xQ2 2025: 1.1xQ3 2025: 1.0xQ4 2025: 1.1xQ1 2026: 1.2xQ2 2026: 0.8xQ3 2026: 0.8x
QuarterNet LeverageStatus
Q3 20260.8xVery low
Q2 20260.8xVery low
Q1 20261.2xHealthy
Q4 20251.1xHealthy
Q3 20251.0xVery low
Q2 20251.1xHealthy
Q1 20251.1xHealthy
Q4 20241.2xHealthy

DORM's net debt is less than a year of its operating earnings (EBITDA).

NIO Net Leverage

NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

DORM Weekly Momentum

MetricValueStatus
RSI53.7Neutral
Stochastic49.5Neutral

DORM's weekly RSI is 54 (neutral) and its Stochastic is 50 (neutral).

NIO Weekly Momentum

MetricValueStatus
RSI30.7Neutral
Stochastic6.9Oversold

NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).

DORM PE vs Consumer Cyclical Sector

MetricDORMSector medianRelative
PE20x18x9% above
PE %244723 pts below

DORM is trading at 20x earnings, in line with the Consumer Cyclical sector's median of 18x.

NIO PE vs Consumer Cyclical Sector

NIO has no meaningful PE right now: it lost money over the past year.

DORM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$127.73.4% above
20 week MA$131.30.5% above
50 week MA$124.65.9% above
100 week MA$128.62.7% above
200 week MA$110.320% above

DORM has the edge over NIO on trend strength, trading above more of its moving averages.

NIO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.369.2% below
20 week MA$4.0124% below
50 week MA$4.8137% below
100 week MA$4.8537% below
200 week MA$6.0349% below

NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.

DORM Yearly ROI

YearStart priceEnd priceROI
2020$75.1$89.6+19%
2021$89.6$106.4+19%
2022$106.4$81.3-24%
2023$81.3$83.4+2.6%
2024$83.4$132.2+58%
2025$132.2$126.6-4.2%
2026 YTD$126.6$132.0+4.2%

DORM has the edge over NIO on returns for 2026, with the stronger performance.

NIO Yearly ROI

YearStart priceEnd priceROI
2020$2.42$45.8+1791%
2021$45.8$30.5-33%
2022$30.5$11.0-64%
2023$11.0$9.07-17%
2024$9.07$4.48-51%
2025$4.48$5.10+14%
2026 YTD$5.10$3.05-40%

NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.

Give your agent the market.

Get API key